# Effects of Pleconaril Nasal Spray on Common Cold Symptoms and Asthma Exacerbations Following Rhinovirus Exposure (Study P04295)

> **NCT00394914** · PHASE2 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 311 (actual)

## Conditions studied

- Asthma
- Common Cold
- Picornavirus Infection
- Rhinovirus

## Interventions

- **DRUG:** Pleconaril
- **DRUG:** Placebo to Pleconaril

## Key facts

- **NCT ID:** NCT00394914
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 311 (ACTUAL)
- **Last updated:** 2015-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00394914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00394914, "Effects of Pleconaril Nasal Spray on Common Cold Symptoms and Asthma Exacerbations Following Rhinovirus Exposure (Study P04295)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00394914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*